The US dollar rose on Monday, to extend its gains for the second straight day and hit a 3-week high, on strong demand and investors' risk aversion due to concerns over the US bond market, ahead of US data later today. 

The dollar index rose 0.2% to the highest since February 8 at 91.12 points, after opening at 90.92 points, and hit a low of 90.68, after gaining 0.8% on Friday, in its biggest daily gain since May 11, 2020.

The dollar index gained more than 0.3% during February, posting the second consecutive monthly gain, due to investors ’risk aversion, after the US Treasury yields rallied.

The yield on the US 10-year Treasury rose by more than 2.0% on Monday, resuming its gains that were temporarily halted on Friday as part of the correction from the highest level in a year.

The yield of the US 10-year Treasury rose by more than 2.0% on Monday, after falling due to profit-taking from a 1-year high.

This surge in the US Treasury bond yields led investors to shun riskier assets, amid rising bets the US Fed would scale back monetary policy easing programs to counter the rising inflation.

At 15:00 GMT, the US ISM manufacturing PMI is expected at 58.5, from 58.7 points.

European stocks rose on Monday, rebounding from a 3-week low, as most global stock markets recovered today after a drop in the US Treasury bond yields and the latest positive updates regarding the Covid-19 vaccines.

The Stoxx Europe 600 index rose 1.2% as of 11:45 GMT, after it closed lower by 1.6% on Friday, after hitting a 3-week low at 404 points.

The pan European index lost 2.4% last week, in its first weekly loss in a month, due to concerns over the US bond market.

The retail sector saw the largest gains in Europe today, rising around 2.5%, as most global retail stocks recovered.

The US Food and Drug Administration (FDA) approved on Saturday the emergency use of the Johnson & Johnson's Covid-19 vaccine, making it the third vaccine that will be widely used in the US.

This vaccine is taken in only a single dose, and can be stored in normal cold temperatures, which makes it easier for distribution in most parts of the world.

US officials said that initial shipments have already started on Sunday, and Johnson & Johnson expects to ship more than 20 million doses by March 30 and 100 million doses by the middle of this year.

S&P 500 futures rose 1.1%, after the index closed lower by 0.5% and hit a 3-week low of 3,789.54 points on Friday at Wall Street.

Back to Europe, the Euro Stoxx 50 index rose 1.1%, France's CAC 40 rose 1.2%, and Germany DAX index rose 0.9%, the UK's FTSE 100 rose 1.5%.

Oil prices rose on Monday, to resume gains after taking a pause on Friday on profit-taking from a 13-month high. Today's rebound comes thanks to hopes about the US stimulus measures and the latest positive updates regarding the Covid-19 vaccines.

US crude rose 2.2% to $62.90 a barrel, after opening at $61.53, and hit a low of $61.53, and Brent crude rose 2.2% to $65.90 a barrel, after opening at $64.50, and hit a low of $64.50.

US crude lost 3.0% on Friday, and Brent crude futures fell 3.9%, in their second straight daily loss on profit-taking from a 13-month high.

Oil prices gained around 17.5% during, in the fourth consecutive monthly gain, as the oversupply concerns receded after OPEC Plus compliance with the agreed supply cuts and Saudi Arabia's voluntary cut.

The US House of Representatives passed a $1.9 trillion Covid-19 relief package on Saturday, after the Democrats who control the House passed the bill by 219 votes to 212 votes, and the bill was sent to the Senate for a final vote.

The US Food and Drug Administration (FDA) approved on Saturday the emergency use of the Johnson & Johnson's Covid-19 vaccine, making it the third vaccine that will be widely used in the US.

This vaccine is taken in only a single dose, and can be stored in normal cold temperatures, which makes it easier for distribution in most parts of the world.

US officials said that initial shipments have already started on Sunday, and Johnson & Johnson expects to ship more than 20 million doses by March 30 and 100 million doses by the middle of this year.

Oil prices continued to rise as the US market opened on Monday, to resume gains after taking a pause on Friday on profit-taking from a 13-month high. Today's rebound comes thanks to hopes about the US stimulus measures and the latest positive updates regarding the Covid-19 vaccines.

US crude rose 2.2% to $62.90 a barrel, after opening at $61.53, and hit a low of $61.53, and Brent crude rose 2.2% to $65.90 a barrel, after opening at $64.50, and hit a low of $64.50.

US crude lost 3.0% on Friday, and Brent crude futures fell 3.9%, in their second straight daily loss on profit-taking from a 13-month high.

Oil prices gained around 17.5% during, in the fourth consecutive monthly gain, as the oversupply concerns receded after OPEC Plus compliance with the agreed supply cuts and Saudi Arabia's voluntary cut.

The US House of Representatives passed a $1.9 trillion Covid-19 relief package on Saturday, after the Democrats who control the House passed the bill by 219 votes to 212 votes, and the bill was sent to the Senate for a final vote.

The US Food and Drug Administration (FDA) approved on Saturday the emergency use of the Johnson & Johnson's Covid-19 vaccine, making it the third vaccine that will be widely used in the US.

This vaccine is taken in only a single dose, and can be stored in normal cold temperatures, which makes it easier for distribution in most parts of the world.

US officials said that initial shipments have already started on Sunday, and Johnson & Johnson expects to ship more than 20 million doses by March 30 and 100 million doses by the middle of this year.